Physician profile
Ivan Ramos
NPI 1184602781
$1,259.22
in general payments reported to CMS, 2019-2025
14 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $102 · 2021: $50.00 · 2022: $186 · 2023: $82.84 · 2024: $309 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $416.46 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $206.96 | 2024 | Watchman Flx, Rezum Generator |
| Astrazeneca Pharmaceuticals LP | $139.17 | 2019-2024 | Farxiga, Lokelma |
| Terumo Medical Corporation | $117.15 | 2025 | Access |
| E.R. Squibb & Sons, L.L.C. | $64.08 | 2019-2025 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.33 | 2024-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.76 | 2025 | Lifevest |
| Mylan LLC | $43.33 | 2019 | |
| Pbg Puerto Rico LLC | $42.65 | 2022-2023 | |
| Abbott Laboratories | $36.93 | 2024 | Assurity |
| Abbvie INC. | $20.00 | 2019 | |
| Merck Sharp & Dohme LLC | $20.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.00 | 2019 | |
| Chiesi USA, INC. | $19.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.